G

Genenta Science SpA
D

GNTA

3.94000
USD
-0.26
(-6.19%)
مغلق
حجم التداول
12
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
72,062,072
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABCL
    -0.10500
    (-3.34%)
    3.04000 USD
    BNTX
    BNTX
    2.240
    (1.90%)
    120.100 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EXAS
    -0.270
    (-0.55%)
    49.250 USD
    G
    GH
    -4.510
    (-9.51%)
    42.910 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NVAX
    0.05500
    (0.69%)
    7.98000 USD
    PFE
    PFE
    0.405
    (1.56%)
    26.305 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    T
    TDOC
    -1.190
    (-9.38%)
    11.490 USD
    المزيد
الأخبار
المقالات

العنوان: Genenta Science SpA

القطاع: Healthcare
الصناعة: Biotechnology
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.